DK2029168T3 - HIV-1 Clade A konsensussekvenser, antigener og transgener. - Google Patents

HIV-1 Clade A konsensussekvenser, antigener og transgener.

Info

Publication number
DK2029168T3
DK2029168T3 DK07798067.0T DK07798067T DK2029168T3 DK 2029168 T3 DK2029168 T3 DK 2029168T3 DK 07798067 T DK07798067 T DK 07798067T DK 2029168 T3 DK2029168 T3 DK 2029168T3
Authority
DK
Denmark
Prior art keywords
clade
transgenes
hiv
antigens
consensus sequences
Prior art date
Application number
DK07798067.0T
Other languages
Danish (da)
English (en)
Inventor
Kalpana Gupta
Nicholas Jackson
Original Assignee
Int Aids Vaccine Initiative
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Int Aids Vaccine Initiative filed Critical Int Aids Vaccine Initiative
Application granted granted Critical
Publication of DK2029168T3 publication Critical patent/DK2029168T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/702Specific hybridization probes for retroviruses
    • C12Q1/703Viruses associated with AIDS
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53DNA (RNA) vaccination
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/10011Adenoviridae
    • C12N2710/10311Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16111Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16211Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16311Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16322New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK07798067.0T 2006-06-02 2007-06-04 HIV-1 Clade A konsensussekvenser, antigener og transgener. DK2029168T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81081606P 2006-06-02 2006-06-02
PCT/US2007/070321 WO2007143606A2 (en) 2006-06-02 2007-06-04 Hiv-1 clade a consensus sequences, antigens, and transgenes

Publications (1)

Publication Number Publication Date
DK2029168T3 true DK2029168T3 (da) 2013-01-14

Family

ID=38802278

Family Applications (2)

Application Number Title Priority Date Filing Date
DK07798067.0T DK2029168T3 (da) 2006-06-02 2007-06-04 HIV-1 Clade A konsensussekvenser, antigener og transgener.
DK11005764.3T DK2399602T3 (en) 2006-06-02 2007-06-04 HIV-1 clade-A CONSENSUS SEQUENCES, ANTIGENS AND TRAN GENES

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK11005764.3T DK2399602T3 (en) 2006-06-02 2007-06-04 HIV-1 clade-A CONSENSUS SEQUENCES, ANTIGENS AND TRAN GENES

Country Status (8)

Country Link
US (2) US8119144B2 (https=)
EP (2) EP2399602B1 (https=)
JP (1) JP2009539353A (https=)
AU (1) AU2007256717B2 (https=)
CA (1) CA2654324A1 (https=)
DK (2) DK2029168T3 (https=)
ES (2) ES2396915T3 (https=)
WO (1) WO2007143606A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9238679B2 (en) * 2011-02-11 2016-01-19 The Trustees Of The University Of Pennslyvania Nucleic acid molecule encoding hepatitis B virus core protein and surface antigen protein and vaccine comprising the same
US20160256539A1 (en) * 2013-11-14 2016-09-08 The Trustees Of The University Of Pennsylvania HIV-1 ENV DNA Vaccine Plus Protein Boost Delivered by EP Expands B- and T-Cell Response and Neutralizing
KR20240137107A (ko) 2019-07-16 2024-09-19 길리애드 사이언시즈, 인코포레이티드 Hiv 백신, 및 이의 제조 및 사용 방법
US12053517B2 (en) 2021-01-14 2024-08-06 Gilead Sciences, Inc. HIV vaccines and methods of using

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5833975A (en) 1989-03-08 1998-11-10 Virogenetics Corporation Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence
IL73534A (en) 1983-11-18 1990-12-23 Riker Laboratories Inc 1h-imidazo(4,5-c)quinoline-4-amines,their preparation and pharmaceutical compositions containing certain such compounds
US5057540A (en) 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
US5238944A (en) 1988-12-15 1993-08-24 Riker Laboratories, Inc. Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine
US6780407B1 (en) 1989-03-08 2004-08-24 Aventis Pasteur Pox virus comprising DNA sequences encoding CEA and B7 antigen
US6309647B1 (en) 1999-07-15 2001-10-30 Aventis Pasteur Poxvirus—canine dispemper virus (CDV) or measles virus recombinants and compositions and methods employing the recombinants
US6277558B1 (en) 1990-11-30 2001-08-21 Kansas University Medical Center α-3 chain type IV collagen polynucleotides
US5650398A (en) 1992-07-02 1997-07-22 Cambridge Biotech Corporation Drug delivery enhancement via modified saponins
PT799058E (pt) 1994-12-24 2003-11-28 Univ Cambridge Tech Melhoramentos na funcao endometrica ou com ela relacionados
US6156567A (en) 1996-07-03 2000-12-05 Merial Truncated transcriptionally active cytomegalovirus promoters
US6090393A (en) 1996-07-03 2000-07-18 Merial Recombinant canine adenoviruses, method for making and uses thereof
US6231859B1 (en) 1996-12-02 2001-05-15 Aquila Biopharmaceuticals, Inc. Saponin adjuvant compositions
US20020136722A1 (en) 1997-06-18 2002-09-26 Heath Andrew William Vaccination method
CA2302522C (en) 1997-08-29 2010-08-17 Antigenics Llc Compositions comprising the adjuvant qs-21 and polysorbate or cyclodextrin as excipient
US6693086B1 (en) 1998-06-25 2004-02-17 National Jewish Medical And Research Center Systemic immune activation method using nucleic acid-lipid complexes
US6913922B1 (en) 1999-05-18 2005-07-05 Crucell Holland B.V. Serotype of adenovirus and uses thereof
US6492169B1 (en) 1999-05-18 2002-12-10 Crucell Holland, B.V. Complementing cell lines
AU784679B2 (en) 1999-12-23 2006-05-25 International Aids Vaccine Initiative Improvements in or relating to immune responses to HIV
JP2004507231A (ja) 2000-06-15 2004-03-11 アメリカ合衆国 免疫応答を向上させるための、gm−csfを発現する組換え非−複製性ウィルスおよびその使用
IT1318103B1 (it) 2000-07-03 2003-07-23 Nuovo Pignone Spa Sistema di connessione tra un ugello di bassa pressione ed untransition duct in una turbina a gas
BRPI0414443A (pt) * 2003-09-17 2006-11-21 Univ Duke imunógenos consensuais/ancestrais
WO2005047483A2 (en) * 2003-11-12 2005-05-26 Medical Research Council Renta: an hiv immunogen and uses thereof

Also Published As

Publication number Publication date
EP2029168B1 (en) 2012-10-03
AU2007256717B2 (en) 2013-06-20
WO2007143606A2 (en) 2007-12-13
US20080089909A1 (en) 2008-04-17
JP2009539353A (ja) 2009-11-19
EP2399602B1 (en) 2014-11-26
EP2029168A2 (en) 2009-03-04
AU2007256717A1 (en) 2007-12-13
CA2654324A1 (en) 2007-12-13
WO2007143606A9 (en) 2008-02-14
EP2399602A1 (en) 2011-12-28
EP2029168A4 (en) 2010-10-27
ES2528951T3 (es) 2015-02-13
US8119144B2 (en) 2012-02-21
DK2399602T3 (en) 2015-02-23
US8735542B2 (en) 2014-05-27
US20120219577A1 (en) 2012-08-30
WO2007143606A3 (en) 2008-11-13
ES2396915T3 (es) 2013-03-01

Similar Documents

Publication Publication Date Title
DK2376015T3 (da) Pneumopedisk-ortodontisk instrument, system og fremgangsmåde.
DK2155382T3 (da) Fremgangsmåde til fremstilling af en skalkatalysator, skalkatalysator og anvendelse deraf
DK2051975T3 (da) Substituerede prolinamider, fremstilling deraf og anvendelse deraf som lægemiddel.
DK2209375T3 (da) Parp-inhibitorforbindelser, præparater og fremgangsmåder til anvendelse deraf
DK2143792T3 (da) Enkelt-strenget, cyklisk RNA, og en fremgangsmåde til fremstilling deraf
DK2032598T3 (da) Axmi-031, axmi-039, axmi-040 og axmi-049, en familie af deltaendotoksingener og fremgangsmåder til deres anvendelse
BRPI0807896A2 (pt) Fórceps bipolares não-aderentes.
DK2061814T3 (da) Antistoffer og immunokonjugater og anvendelse deraf.
DK2219726T3 (da) Medicinsk elektrode, elektrodebundt og elektrodebundt-sæt
DK2259853T3 (da) Legetøjsklods, legetøjsklodsforbindelsesled og legetøjsklodselement til fremstilling af en legetøjsklods
DK1954808T3 (da) Enzympræparat, der giver en ren smag
DK2134663T3 (da) Beskyttelseslag på højtemperaturudholdende chromoxiddannende substrater, og fremgangsmåde til fremstilling deraf
BRPI0718974A2 (pt) Copolímero, e, método para preparar um copolímero
DK2350026T3 (da) Sulfoximinsubstituerede anilinopyrimidinderativer som cdk-inhibitorer, fremstilling og anvendelse heraf som lægemiddel
EP2030018A4 (en) REVERSE PHASE PROTEIN ARRAY, PROTEIN ACTIVATION AND EXPRESSION SIGNATURES AND CORRESPONDING METHODS
DK1988090T3 (da) Imidazol-5-carboxylsyrederivater, fremgangsmåder til fremstilling af disse og anvendelse deraf
DK2240487T3 (da) Triazolopyridaziner som para-inhibitorer, fremstilling og anvendelse heraf som lægemiddel
BRPI0921081A2 (pt) síntese de peptídeos usando a ativação e o acoplamento enzimático.
GB0602992D0 (en) Methods, genes and proteins
DK2029168T3 (da) HIV-1 Clade A konsensussekvenser, antigener og transgener.
DK2217619T3 (da) Cyklisk, cystein-frit protein
MX314942B (es) Fosfonatos reactivos.
ITTO20050241A1 (it) Impianto dentario intraosseo.
DK2037863T3 (da) Gastronomi-sonde, fremstillingsfremgangsmåder dertil og indføringsværktøj
ITTO20070117U1 (it) Riscaldatore a gas